Microbiome and metagenomics analysis using MGnify, GTDB taxonomy, ENA sequencing data, and EuropePMC literature. Covers taxonomic classification, genome quality assessment, biome-clinical phenotype linkage, and pathway interpretation. Use for amplicon/shotgun metagenomics study analysis.
The canonical home for this skill is tooluniverse-metagenomics-analysis in mims-harvard/ToolUniverse
Integrated pipeline for exploring microbiome studies, classifying taxa, assessing genome quality, linking microbial composition to clinical phenotypes, and interpreting findings through pathway analysis and literature context.
Guiding principles:
When uncertain about any scientific fact, SEARCH databases first rather than reasoning from memory.
When analysis requires computation (statistics, data processing, scoring, enrichment), write and run Python code via Bash. Don't describe what you would do — execute it and report actual results. Use ToolUniverse tools to retrieve data, then Python (pandas, scipy, statsmodels, matplotlib) to analyze it.
| Database | Best For |
|---|---|
| MGnify | Processed metagenomics studies, taxonomic/functional results |
| GTDB | Standardized bacterial/archaeal taxonomy, species-level resolution |
| GMrepo | Gut species-to-human-health phenotype associations |
| ENA | Raw sequencing datasets and study metadata |
| KEGG | Pathway mapping for microbial functional annotations |
| PubMed/EuropePMC | Published microbiome-disease studies |
| CTD | Chemical-microbiome-disease relationships |
Phase 0: Parse query → organism, biome, phenotype, or accession
Phase 1: Study Discovery → MGnify_search_studies, ENAPortal_search_studies
Phase 2: Taxonomic Classification → GTDB_search_genomes, GTDB_get_species, GTDB_search_taxon
Phase 3: Genome Quality → MGnify_search_genomes, MGnify_get_genome (CheckM metrics)
Phase 4: Functional Annotation → MGnify GO terms + KEGG pathway mapping
Phase 5: Clinical Associations → GMrepo species-phenotype links
Phase 6: Literature → PubMed/EuropePMC + CTD gene-disease
Phase 7: Interpretation & Report SynthesisPhase 1: ENA requires structured queries (e.g., study_title="*IBD*"), not free text. If ENA fails, fall back to MGnify.
Phase 2: GTDB uses its own naming (e.g., s__Bacteroides_A fragilis vs NCBI Bacteroides fragilis). Always note discrepancies. Use GTDB_search_taxon(operation="search_taxon", query=name).
Phase 3 - Quality tiers (MIMAG):
Phase 4 - Functional interpretation: Don't just list GO terms. Connect to biology:
| Functional Category | Key KEGG Pathways | Significance |
|---|---|---|
| SCFA production | map00650, map00640 | Gut barrier, anti-inflammatory |
| LPS biosynthesis | map00540 | Pro-inflammatory, endotoxemia |
| Bile acid metabolism | map00120 | Fat absorption, FXR signaling |
| Tryptophan metabolism | map00380 | Serotonin, AhR, immune |
| Vitamin biosynthesis | map00730/740/760 | Host nutritional contribution |
Use kegg_search_pathway(keyword=...) (NOT query). Pathway IDs need organism prefix (hsa, ko, eco), NOT bare map.
Phase 5: GMrepo uses MeSH terms: "Crohn Disease" not "IBD", "Colitis, Ulcerative" not "UC", "Colorectal Neoplasms" not "colorectal cancer". Try NCBI taxon IDs if species name fails.
Phase 6 - Evidence grading:
Phase 7 - Report: Executive summary, study landscape, GTDB taxonomy, functional interpretation (not GO term lists), clinical relevance with evidence grades, mechanistic model, genome catalog with quality tiers, data gaps.
089eb8e
Canonical home
since Jul 28, 2026
If you maintain this skill, you can claim it as your own. Once claimed, you can manage eval scenarios, bundle related skills, attach documentation or rules, and ensure cross-agent compatibility.